orogo
Solicitar cotización

Modified Nucleotides

NaMTP(αS) TEA Salt

Quick view. A ribonucleoside triphosphate analog combining the NaM 3-methoxy-2-naphthyl base with an alpha-phosphorothioate group. The alpha-phosphorus configuration and triethylammonium stoichiometry are unspecified. CAS N/A. Catalog target purity: By inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.

Request a quote Review request checklist

Structure of NaMTP alpha-phosphorothioate TEA salt
Chemical structure
Catalog numberOR-MN-0127
CAS numberN/A
PurityBy inquiry
Pack sizeCustom packaging by inquiry

Product profile

Material identity

NaMTP(αS) TEA Salt is classified as modified nucleotides.

Typical application

NaMTP(αS) TEA Salt is supplied for research use within the Modified Nucleotides product family.

Handling focus

For NaMTP(αS) TEA Salt, confirm the current specification, storage conditions and downstream-method compatibility before routine use.

Names and search terms

Confirmed or normalized name variants

Physicochemical data

Unnatural baseNaM (3-methoxy-2-naphthyl)
Sugar typeRibose
Phosphate state5'-Triphosphate
Phosphorothioate positionAlpha phosphate
Alpha-phosphorus stereochemistryUnspecified
CounterionTriethylammonium, stoichiometry unspecified

Release documentation

Lot-specific CoA

The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.

Analytical package

Additional HPLC, MS or NMR documentation can be agreed during technical review where available.

Related products

OR-INTE-0013

3'-OMe-GDP Disodium Salt

Modified Nucleotides · CAS: N/A

OR-INTE-0014

3'-OMe-GMP

Modified Nucleotides · CAS: 400806-41-9

OR-INTE-0015

3'-OMe-GMP TEA Salt

Modified Nucleotides · CAS: 860605-85-2

OR-INTE-0021

Im-3'-OMe-GMP

Modified Nucleotides · CAS: 1005791-93-4

OR-INTE-0023

Im-GDP

Modified Nucleotides · CAS: 1199264-75-9

OR-MN-0025

(-)-Emtricitabine Triphosphate Tetrasodium Salt

Modified Nucleotides · CAS: 1188407-46-6

Feature and workflow background

These publications discuss a broader chemistry feature or workflow identified from the catalog name or product family. They are background reading only, not evidence for the exact OROGO product, supplied form, lot specification, availability or performance.

Related OROGO articles

These editorial links discuss the product family, workflow or sourcing context. They are not lot specifications or evidence that every statement applies to this product.

OROGO article

Key Quality Attributes for Modified Nucleotides

Important quality attributes for modified nucleotide sourcing, including purity basis, water content, counterion, storage and enzyme compatibility.

OROGO article

RNA-Based Skincare Is Becoming a Materials Question

PDRN, siRNA, miRNA and tFNA are being discussed together in skincare, but they are different materials with different evidence and formulation questions.

OROGO article

INTerpath-001 Is Positive, but the Phase 3 Effect Size Is Still Missing

INTerpath-001 met RFS and DMFS endpoints, but Phase 3 effect sizes, subgroup results and mature overall survival data remain pending.

Request a quote Review request checklist

Technology platforms

Catalog-derived platform membership for navigating related chemistry and verifiable product sets.

Nucleoside & nucleotide chemistry

View platform scope

mRNA raw-material platform

View platform scope

General selection guidance for evaluating this product family. Confirm the exact product specification and workflow requirements separately.

Choosing modified nucleosides and nucleotides

Review form, hydration, workflow compatibility, analytical basis and storage before use.

Open technical guide